Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
Phase 2, open label, multicenter study of pacritinib in relapsed/refractory T-cell lymphoproliferative neoplasms
Clinical Trial Grant
Duke Scholars
Principal Investigator
Jie Wang
Medicine, Hematological Malignancies
Awarded By
University of Michigan
Start Date
August 6, 2024
End Date
July 31, 2029
Awarded By
University of Michigan
Start Date
August 6, 2024
End Date
July 31, 2029
